Q4 results was challenging driven by steep fall in CDMO revenues and higher upfront cost of Capex projects and R&D projects
The funding will be used to expand the product line for remote patient monitoring and to scale the business across Asia and Africa
Bridging the gap between histopathology and molecular pathology
Enabling clinical effectiveness via a fully interoperable and integrated digital pathology solution
The acquisition is a crucial step in LTS' strategy to broaden its portfolio of drug delivery platforms.
Fully equipped labs with 75-member team set-up and made operational in <100 days
Showcased digital innovations: MyPKFit, SYNAPSE and Athena at the G20 Health Working Group Meeting
WuXi Bio provided technical services, based on the companies' versatile integrated service platforms, to support various manufacturing and process development activities of these ADC product candidates.
Digitization has unleashed a flood of data that presents a huge opportunity but is also overwhelming clinicians, nurses, and administrators
Subscribe To Our Newsletter & Stay Updated